Drug Take-Back Programs Likely To Grow As Supreme Court Denies PhRMA Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
More than 250 pharma companies participating in take-back project in Alameda while Exelixis has individual program for Cometriq.